Media Room Menu
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 12, 2017-- More adults reached HbA(1c) target at 8 and 12 weeks versus those receiving insulin glargine 100 Units/mL --
-
Sep 11, 2017- Investigational dupilumab reduced severe asthma attacks and improved lung function -
-
Aug 28, 2017- An innovative quadrivalent influenza vaccine will complement Sanofi Pasteur vaccine portfolio -
-
Jul 17, 2017- Health care providers anticipating initial shipments by early August to kick off influenza immunization season -
-
Jul 11, 2017- Acquisition adds recombinant-based influenza vaccine to Sanofi Pasteur’s portfolio -
-
Jun 11, 2017- Data presented at the 77th Scientific Sessions of the American Diabetes Association (ADA) -
-
Jun 10, 2017- New DELIVER 3 Real-World Toujeo® Observational Study Confirms Reduction of Hypoglycemia in Real-Life Setting -
-
Jun 10, 2017- All subgroups treated with Soliqua 100/33 achieved a mean HbA1c of below 7 percent after 30 weeks -
-
Jun 4, 2017- Oral presentation provides first REGN2810 data in patients with advanced cutaneous squamous cell carcinoma (CSCC) -
-
May 22, 2017- Kevzara is now available to U.S. patients -
-
May 11, 2017-- New Initiative Encourages Americans to Help Reduce Air Pollution & Enjoy the Outdoors this Spring Allergy Season --
-
May 2, 2017- New U.S. survey reveals significant unmet needs when it comes to treatments and support for those living with RA -
-
Apr 28, 2017- New action date for Kevzara U.S. BLA is May 22, 2017 -
-
Apr 25, 2017- Monthly dosing schedule now approved in both United States and European Union -
